Vancouver, Canada · Founded 2023 · Privately Held (backing)
Developer of a cytokine therapy designed for cancer treatment and promoting targeted immune activation while limiting toxicity. Reverb Therapeutics is based in Vancouver, Canada and was founded in 2023. It has raised $12.5 million.
Last price · $/share
—
Implied valuation
—
Total raised
$12.5M
Last round
—
Cap table — not yet on record
Reverb Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Reverb Therapeutics with a free account
·Watch Reverb Therapeutics: the Monday email on marks, rounds and moves
